{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:20:55Z","timestamp":1764249655607,"version":"3.46.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SH1324N"],"award-info":[{"award-number":["1SH1324N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds UGent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>\n                    CD94 is a natural killer (NK) cell receptor that also marks subsets of T cells, referred to as NKT cells. In humans, the role of CD94 as both an immune checkpoint and a potential therapeutic target has gained increasing attention. However, data about its expression in leukemia and lymphoma in dogs remain limited. This study aimed to explore CD94 expression in canine leukemia and nodal lymphoma, using a newly available anti-canine CD94 monoclonal antibody in a multicolor flow cytometry panel. Surplus blood and lymph node aspirate samples from eleven client-owned dogs (leukemia:\n                    <jats:italic>n<\/jats:italic>\n                    = 7, lymphoma\n                    <jats:italic>n<\/jats:italic>\n                    = 4) and two clinically healthy controls, were analyzed. The control dogs as well as most cases showed low CD94\n                    <jats:sup>+<\/jats:sup>\n                    lymphocyte frequencies, consistent with a non-neoplastic population. However, markedly expanded CD94\n                    <jats:sup>+<\/jats:sup>\n                    populations were identified in two out of four of the T cell chronic lymphocytic leukemia (T-CLL) cases. In one of them, the neoplastic population was uniformly CD3\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    CD94\n                    <jats:sup>+<\/jats:sup>\n                    , while the other showed a heterogeneous mixture of CD3\n                    <jats:sup>+<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    CD94\n                    <jats:sup>+<\/jats:sup>\n                    and CD3\n                    <jats:sup>\u2212<\/jats:sup>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    CD94\n                    <jats:sup>+<\/jats:sup>\n                    lymphocytes. Our findings demonstrate that the canine-specific CD94 antibody can be applied to both blood and lymph node samples in a diagnostic flow cytometry setting. While CD94 expression was infrequent overall, its detection in a subset of T-CLL cases highlights the need for larger studies to determine its diagnostic and therapeutic value in canine leukemia and lymphoma.\n                  <\/jats:p>","DOI":"10.3389\/fvets.2025.1716800","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:18:10Z","timestamp":1764249490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CD94 as a novel marker for immunophenotyping of leukemia and lymphoma in dogs"],"prefix":"10.3389","volume":"12","author":[{"given":"Anna","family":"Blockeel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristel","family":"Demeyere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Steenbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Paepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Krupa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Devriendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1074-7613(00)80008-4","article-title":"Structure of CD94 reveals a novel C-Type lectin fold","volume":"10","author":"Boyington","year":"1999","journal-title":"Immunity."},{"key":"B2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature."},{"key":"B3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/35642","article-title":"Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells","volume":"391","author":"Lanier","year":"1998","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1385\/IR:35:3:263","article-title":"The CD94\/NKG2 Family of receptors: from molecules and cells to clinical relevance","volume":"35","author":"Borrego","year":"2006","journal-title":"Immunol Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.vetimm.2007.06.013","article-title":"Reactivity of cross-reacting monoclonal antibodies with canine leukocytes, platelets and erythrocytes","volume":"119","author":"Schuberth","year":"2007","journal-title":"Vet Immunol Immunopathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.vetimm.2019.03.005","article-title":"Development and characterization of a canine-specific anti-CD94 (KLRD-1) monoclonal antibody","volume":"211","author":"Graves","year":"2019","journal-title":"Vet Immunol Immunopathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"841859","DOI":"10.3389\/fimmu.2022.841859","article-title":"Examination of IgG Fc receptor CD16A and CD64 expression by canine leukocytes and their ADCC activity in engineered NK Cells","volume":"13","author":"Hullsiek","year":"2022","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.vetmic.2015.01.021","article-title":"The anti-canine distemper virus activities of ex vivo-expanded canine natural killer cells","volume":"176","author":"Park","year":"2015","journal-title":"Vet Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/vco.12695","article-title":"newly established canine NK-type cell line and its cytotoxic properties","volume":"19","author":"Grudzien","year":"2021","journal-title":"Vet Comp Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.exger.2007.05.002","article-title":"Invariant NKT and NKT-like lymphocytes: Two different T cell subsets that are differentially affected by ageing","volume":"42","author":"Peralbo","year":"2007","journal-title":"Exp Gerontol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101241","DOI":"10.1016\/j.xcrm.2023.101241","article-title":"Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients","volume":"4","author":"Rotolo","year":"2023","journal-title":"Cell Rep Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/jcm8111802","article-title":"Characterization and potential applications of dog natural killer cells in cancer immunotherapy","volume":"8","author":"Gingrich","year":"2019","journal-title":"J Clin Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1336158","DOI":"10.3389\/fvets.2024.1336158","article-title":"Improved characterization and translation of NK cells for canine immunotherapy","volume":"11","author":"Razmara","year":"2024","journal-title":"Front Vet Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e007963","DOI":"10.1136\/jitc-2023-007963","article-title":"Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer","volume":"12","author":"Razmara","year":"2024","journal-title":"J Immunother Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"217305","DOI":"10.1016\/j.canlet.2024.217305","article-title":"CD94 deficiency or blockade unleashes the anti-tumor immunity in mice and humanized murine models","volume":"605","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1182\/blood-2022-159242","article-title":"DR-01, a Non-fucosylated anti-CD94 antibody, depletes leukemic cells in ex vivo and in vivo models of large granular lymphocyte leukemia","volume":"140","author":"Shi","year":"2022","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1182\/blood-2024-206053","article-title":"Results from the first phase 1 clinical study of DR-01, a non-fucosylated anti-CD94 targeting antibody in patients with relapsed\/refractory cytotoxic lymphomas: dose escalation and optimization","volume":"144","author":"Zain","year":"2024","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1158\/1078-0432.CCR-19-2095","article-title":"The NKG2A\u2013HLA-E axis as a novel checkpoint in the tumor microenvironment","volume":"26","author":"Borst","year":"2020","journal-title":"Clin Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1162700","DOI":"10.3389\/fimmu.2023.1162700","article-title":"single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs","volume":"14","author":"Ammons","year":"2023","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1571085","DOI":"10.3389\/fimmu.2025.1571085","article-title":"Single cell atlas of canine natural killer cells identifies distinct circulating and tissue resident gene profiles","volume":"16","author":"Razmara","year":"2025","journal-title":"Front Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/TP.0000000000003489","article-title":"Anti-ICOS mAb Targets pathogenic IL-17A-expressing cells in canine model of chronic GVHD","volume":"105","author":"Parker","year":"2021","journal-title":"Transplantation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e632","DOI":"10.1097\/TXD.0000000000001082","article-title":"CD94 ex vivo cultures in a bone marrow transplantation setting","volume":"6","author":"Abrams","year":"2020","journal-title":"Transplant Direct."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1182\/blood-2002-08-2408","article-title":"Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C\/E and NKD2D killer cell receptors","volume":"101","author":"Bigouret","year":"2003","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"publisher","first-page":"106614","DOI":"10.1016\/j.leukres.2021.106614","article-title":"CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations","volume":"108","author":"Fang","year":"2021","journal-title":"Leuk Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1182\/blood.V95.11.3628.011k35_3628_3630","article-title":"Expression of CD94\/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas","volume":"95","author":"Haedicke","year":"2000","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1182\/blood-2005-02-0519","article-title":"CD94 1A transcripts characterize lymphoblastic lymphoma\/leukemia of immature natural killer cell origin with distinct clinical features","volume":"106","author":"Lin","year":"2005","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.20892\/j.issn.2095-3941.2023.0464","article-title":"A retrospective analysis of mature T- and NK-cell lymphomas","volume":"21","author":"Jia","year":"2024","journal-title":"Cancer Biol Med."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1716800\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:18:11Z","timestamp":1764249491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1716800\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":28,"alternative-id":["10.3389\/fvets.2025.1716800"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1716800","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"article-number":"1716800"}}